Neoadjuvant chemotherapy for breast cancer: Pathologic response rates but not tumor size, has an independent prognostic impact on survival.
Gilles Houvenaeghel, Alexandre de Nonneville, Monique Cohen...
https://pubmed.ncbi.nlm.nih.gov/38327130Actively Recruiting
Age: 18Years +
All Genders
ID02869607
Institut Paoli Calmettes Breast Cancer Database
Led by Institut Paoli-Calmettes · Updated on 2016-08-17
45000
Participants Needed
1
Research Sites
47 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research involves creating a database of patients diagnosed with breast cancer at Institut Paoli-Calmettes. The study aims to collect detailed patient information and track survival outcomes over a period of 10 years to better understand breast cancer characteristics and patient longevity. Participants in this observational study are included based on their diagnosis of breast cancer. The study involves collecting data from these patients, with no experimental treatments or interventions being administered. The focus is on gathering and analyzing patient characteristics and survival data over time. During the study, participants' medical information and outcomes will be monitored and recorded for up to 10 years. Researchers will assess survival rates and compile patient characteristics to improve knowledge about breast cancer. There is no active treatment or additional procedures required as part of this study, and participation may continue throughout the observation period until the study concludes.
CONDITIONS
Brief Title
Institut Paoli Calmettes Breast Cancer Database
Who Can Participate
Age: 18Years +
All Genders
Eligibility Criteria
You may qualify if you...
- Patient with a diagnosis of breast cancer
- Age 18 years or older
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Long-term Monitoring
Duration - Up to 10 years
Participants are observed over time to collect data on survival and patient characteristics related to breast cancer.
Trial Site Locations
Total: 1 location
1
Institut Paoli Calmettes
Marseille, Bouches du Rhone, France, 13009
Actively Recruiting
Loading map...
Research Team
D
Dominique Genre, MD
L
Lilian Laborde
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
Lack of prognostic impact of sentinel node micro-metastases in endocrine receptor-positive early breast cancer: results from a large multicenter cohort☆.
G Houvenaeghel, A de Nonneville, M Cohen...
https://pubmed.ncbi.nlm.nih.gov/33984674